Data / Form D filings / Sequel Pharmaceuticals Inc
Sequel Pharmaceuticals Inc: Form D filings
Sequel Pharmaceuticals Inc, a pharmaceuticals company in San Diego, CA, filed 3 Form D notices with the SEC between 2009 and 2010. The latest, on December 23, 2010, reports $1 million sold of a $9 million offering to 10 investors.
Find out what Sequel Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12790 EL CAMINO REAL, Suite 300, San Diego, CA, 92130
- Phone
- (858) 509-0455
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1414879
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2010 | New notice | $9,000,000 | $1,000,000 | $8,000,000 | 10 | Dec 21, 2010 | sec.gov |
| Sep 7, 2010 | New notice | $1,963,532 | $1,367,579 | $595,953 | 11 | Aug 30, 2010 | sec.gov |
| Aug 11, 2009 | New notice | $8,412,727 | $3,005,455 | $5,407,272 | 12 | Aug 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark C. Murgerditchian | Executive Officer | |
| Eckard K. Weber | Director | |
| Brian K. Farmer | Executive Officer | |
| Joseph K. Turner | Director | |
| Randall Woods | Executive Officer, Director | |
| Paul K. Chamberlain | Executive Officer | |
| Daniel K. Turner, III | Director | |
| Stuart J.M. Collinson | Director | |
| Howard C. Dittrich | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 20, 2010 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sequel Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.